Pinho S, Gardner G, Alva R, Stuart J, Cunha-Oliveira T
Methods Mol Biol. 2024; 2878():163-199.
PMID: 39546262
DOI: 10.1007/978-1-0716-4264-1_9.
Abbott K, Subudhi S, Ferreira R, Gultekin Y, Steinbuch S, Munim M
bioRxiv. 2024; .
PMID: 39484531
PMC: 11527034.
DOI: 10.1101/2024.10.24.616714.
Flickinger K, Wilson K, Rossiter N, Hunger A, Vishwasrao P, Lee T
Sci Adv. 2024; 10(40):eadq3591.
PMID: 39365851
PMC: 11451515.
DOI: 10.1126/sciadv.adq3591.
Jonker P, Muir A
Dis Model Mech. 2024; 17(9).
PMID: 39284708
PMC: 11423921.
DOI: 10.1242/dmm.050814.
Sivanand S, Gultekin Y, Winter P, Vermeulen S, Tchourine K, Abbott K
Nat Metab. 2024; 6(9):1668-1681.
PMID: 39160333
PMC: 11450831.
DOI: 10.1038/s42255-024-01105-9.
Micronutrients Importance in Cancer Prevention-Vitamins.
Saeed R, Naz S, Awan U, Gul S, Subhan F, Saeed S
Cancer Treat Res. 2024; 191:119-144.
PMID: 39133406
DOI: 10.1007/978-3-031-55622-7_5.
Drug screening in human physiologic medium identifies uric acid as an inhibitor of rigosertib efficacy.
Rawat V, DeLear P, Prashanth P, Ozgurses M, Tebeje A, Burns P
JCI Insight. 2024; 9(13).
PMID: 38815134
PMC: 11383364.
DOI: 10.1172/jci.insight.174329.
Metabolite profiling of human renal cell carcinoma reveals tissue-origin dominance in nutrient availability.
Abbott K, Ali A, Reinfeld B, Deik A, Subudhi S, Landis M
Elife. 2024; 13.
PMID: 38787918
PMC: 11126308.
DOI: 10.7554/eLife.95652.
Lipid availability influences ferroptosis sensitivity in cancer cells by regulating polyunsaturated fatty acid trafficking.
Sokol K, Lee C, Rogers T, Waldhart A, Ellis A, Madireddy S
bioRxiv. 2024; .
PMID: 38766165
PMC: 11100758.
DOI: 10.1101/2024.05.06.592780.
Ketogenic therapy towards precision medicine for brain diseases.
Liu Y, Fan L, Yang H, Wang D, Liu R, Shan T
Front Nutr. 2024; 11:1266690.
PMID: 38450235
PMC: 10915067.
DOI: 10.3389/fnut.2024.1266690.
The regulatory relationship between NAMPT and PD-L1 in cancer and identification of a dual-targeting inhibitor.
Yang Y, Li Z, Wang Y, Gao J, Meng Y, Wang S
EMBO Mol Med. 2024; 16(4):885-903.
PMID: 38448544
PMC: 11018795.
DOI: 10.1038/s44321-024-00051-z.
Metabolite profiling of human renal cell carcinoma reveals tissue-origin dominance in nutrient availability.
Abbott K, Ali A, Reinfeld B, Deik A, Subudhi S, Landis M
bioRxiv. 2024; .
PMID: 38187626
PMC: 10769456.
DOI: 10.1101/2023.12.24.573250.
Unmasking metabolic dependencies in pancreatic cancer: aberrant polyamine synthesis as a promising new therapeutic target.
Wolters-Eisfeld G, Hackert T, Gungor C
Signal Transduct Target Ther. 2023; 8(1):410.
PMID: 37884518
PMC: 10603029.
DOI: 10.1038/s41392-023-01662-7.
Tumor lipid metabolism: a mechanistic link between diet and cancer progression.
Jeong Y, Rogers T, Anderson C, Lien E
Curr Opin Biotechnol. 2023; 84:102993.
PMID: 37716318
PMC: 10872979.
DOI: 10.1016/j.copbio.2023.102993.
Metabolic partitioning in the brain and its hijacking by glioblastoma.
de Ruiter Swain J, Michalopoulou E, Noch E, Lukey M, Van Aelst L
Genes Dev. 2023; 37(15-16):681-702.
PMID: 37648371
PMC: 10546978.
DOI: 10.1101/gad.350693.123.
Chlorogenic Acid Induced Neuroblastoma Cells Differentiation via the ACAT1-TPK1-PDH Pathway.
You S, Wang M, Hou Z, Wang W, Du T, Xue N
Pharmaceuticals (Basel). 2023; 16(6).
PMID: 37375824
PMC: 10304613.
DOI: 10.3390/ph16060877.
Optimization of energy production and central carbon metabolism in a non-respiring eukaryote.
Alam S, Gu Y, Reichert P, Bahler J, Oliferenko S
Curr Biol. 2023; 33(11):2175-2186.e5.
PMID: 37164017
PMC: 7615655.
DOI: 10.1016/j.cub.2023.04.046.
Metabolic Barriers to Glioblastoma Immunotherapy.
Choudhary N, Osorio R, Oh J, Aghi M
Cancers (Basel). 2023; 15(5).
PMID: 36900311
PMC: 10000693.
DOI: 10.3390/cancers15051519.
Review to Understand the Crosstalk between Immunotherapy and Tumor Metabolism.
Pandey P, Khan F, Upadhyay T, Maqsood R
Molecules. 2023; 28(2).
PMID: 36677919
PMC: 9863813.
DOI: 10.3390/molecules28020862.
Chemosensitivity of 3D Pancreatic Cancer Organoids Is Not Affected by Transformation to 2D Culture or Switch to Physiological Culture Medium.
Gassl V, Aberle M, Boonen B, Vaes R, Olde Damink S, Rensen S
Cancers (Basel). 2022; 14(22).
PMID: 36428711
PMC: 9688175.
DOI: 10.3390/cancers14225617.